MCOW
Pacer S&P MidCap 400 Quality FCF Aristocrats ETF
Pacer S&P MidCp 400 Qul FCF Arstcrts ETF seeks to provide investment results that correspond to the performance of an index comprised of mid-cap companies exhibiting strong free cash flow characteristics.
US
EQUITY
Passive
MANAGEMENT STYLE
$ 1.1 M
ASSETS UNDER MGMT
49 bp
EXPENSES
Fund Basics
| Inception date | Aug 27, 2025 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| DOCUSIGN, INC. | 4.6 % |
| MANHATTAN ASSOCIATES INC | 4.3 % |
| MEDPACE HOLDINGS, INC. | 4.3 % |
| EXELIXIS INC | 3.5 % |
| OKTA, INC. CLASS A | 3.0 % |
| LATTICE SEMICONDUCTOR CORP | 3.0 % |
| QUALYS INC | 2.7 % |
| JAZZ PHARMACEUTICALS PLC | 2.3 % |
| TECHNIPFMC PLC | 2.3 % |
| RAMBUS INC | 2.3 % |
Constituent Breakdown
| Number of holdings | 78 |
| Herfindahl-Hirschman Index | 197 |
| Wgt avg mkt cap (mns) | $11,212 |
| Large cap (>$10bn) | 52.2% |
| Mid cap ($2-10bn) | 46.2% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 99.3% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 92.0 % |
 |
IRELAND | 2.4 % |
 |
BRITAIN | 2.3 % |
 |
BERMUDA | 1.7 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 10.9% | 6.3% | -- | -- | -- | -- | -- | 6.2% |
| Dividend Yield | 0.2% | 0.3% | -- | -- | -- | -- | -- | 0.3% |
| Total Returns | 11.1% | 6.6% | -- | -- | -- | -- | -- | 6.4% | Ann. Volatility | 17.3% | 17.3% | -- | -- | -- | -- | -- | 17.1% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.07 | 64% |
| MSCI EAFE | 0.71 | 42% |
| MSCI Emg Mkts | 0.45 | 43% |
Liquidity Measures
| Avg. volume (000) | 1 |
| ADV traded (mns) | $0 |
| Turnover | 2.0% |
| Avg. Bid/Ask (% of price) | 0.20% |
Technical Indicators
| 30d moving avg. (EMA) | $22.22 |
| Relative strength (RSI) | 58 |
| MACD/Signal | 0.16/0.15 |
| Bollinger Bands (Upper/Lower) | $22.73/$21.88 |
| Short interest (% of AUM) | 0.2% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. MCOW |
Expenses vs. MCOW |
ALTAR Score™ vs. MCOW |
|---|---|---|---|---|
| XMHQ | Invesco S&P MidCap Quality ETF | 42.5% | -19 bp | +0.1% |
| GRPM | Invesco S&P MidCap 400 GARP ETF | 29.3% | -14 bp | +0.7% |
| MDYG | State Street SPDR S&P 400 Mid Cap Growth ETF | 27.7% | -34 bp | -0.8% |
| IVOG | Vanguard S&P Mid-Cap 400 Growth ETF | 27.4% | -39 bp | -0.9% |
| IJK | iShares S&P Mid-Cap 400 Growth ETF | 27.1% | -33 bp | -0.8% |
| RFG | Invesco S&P Midcap 400 Pure Growth ETF | 26.4% | -14 bp | -1.6% |
| PAMC | Pacer Lunt MidCap Multi-Factor Alternator ETF | 21.6% | +11 bp | -3.0% |
| QVMM | Invesco S&P MidCap 400 QVM Multi-factor ETF | 21.1% | -34 bp | +0.5% |
| XJH | iShares ESG Screened S&P Mid-Cap ETF | 21.0% | -37 bp | +0.2% |
| MDY | SPDR S&P Midcap 400 ETF Trust | 20.7% | -26 bp | +0.4% |
Risk and Returns: MCOW vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 11/6/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
6.7%
ALTAR SCORE™
69th
PERCENTILE
OVERWEIGHT
ETFRC RATING
There are 1,388 funds in the US Equity category with an average
ALTAR Score™ of 5.7% and a standard deviation
of 2.1%. MCOW's ALTAR Score™ is approximately 0.5 standard
deviations above the category average. This places MCOW in the 69th percentile
among funds in the category.
Sell-Side Consensus
$26.45
PRICE TARGET
+21.6%
UPSIDE